Cantor Fitzgerald Forecasts Strong Price Appreciation for CVS Health (NYSE:CVS) Stock

CVS Health (NYSE:CVS) had its price objective lifted by analysts at Cantor Fitzgerald from $78.00 to $95.00 in a research report issued on Thursday,Benzinga reports. The brokerage currently has an “overweight” rating on the pharmacy operator’s stock. Cantor Fitzgerald’s target price would indicate a potential upside of 21.60% from the stock’s previous close. Cantor Fitzgerald also issued estimates for CVS Health’s FY2025 earnings at $6.61 EPS and FY2026 earnings at $7.11 EPS.

Other analysts have also issued reports about the stock. UBS Group boosted their price target on shares of CVS Health from $79.00 to $96.00 and gave the stock a “buy” rating in a research note on Friday, October 24th. The Goldman Sachs Group initiated coverage on shares of CVS Health in a research note on Tuesday, October 14th. They set a “buy” rating and a $91.00 price target on the stock. Wall Street Zen upgraded shares of CVS Health from a “hold” rating to a “buy” rating in a research note on Sunday, September 21st. Mizuho boosted their price target on shares of CVS Health from $76.00 to $88.00 and gave the stock an “outperform” rating in a research note on Thursday, October 9th. Finally, Morgan Stanley boosted their price target on shares of CVS Health from $82.00 to $89.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 14th. Two analysts have rated the stock with a Strong Buy rating, twenty have issued a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $86.33.

CVS Health Trading Up 1.9%

Shares of CVS stock opened at $78.13 on Thursday. The company’s 50-day moving average price is $76.49 and its 200-day moving average price is $69.04. CVS Health has a twelve month low of $43.56 and a twelve month high of $85.15. The company has a current ratio of 0.83, a quick ratio of 0.62 and a debt-to-equity ratio of 0.83. The stock has a market cap of $99.09 billion, a price-to-earnings ratio of 205.61, a PEG ratio of 0.87 and a beta of 0.60.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 EPS for the quarter, beating analysts’ consensus estimates of $1.36 by $0.24. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The company had revenue of $102.87 billion for the quarter, compared to analysts’ expectations of $98.85 billion. During the same quarter in the prior year, the company posted $1.09 earnings per share. CVS Health’s revenue for the quarter was up 7.8% compared to the same quarter last year. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. As a group, equities analysts predict that CVS Health will post 5.89 earnings per share for the current year.

Insider Transactions at CVS Health

In related news, Director Anne A. Finucane sold 7,500 shares of the company’s stock in a transaction that occurred on Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total value of $532,650.00. Following the completion of the transaction, the director directly owned 22,156 shares of the company’s stock, valued at $1,573,519.12. This represents a 25.29% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.22% of the stock is owned by company insiders.

Hedge Funds Weigh In On CVS Health

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. SOA Wealth Advisors LLC. increased its position in CVS Health by 36.9% in the 3rd quarter. SOA Wealth Advisors LLC. now owns 486 shares of the pharmacy operator’s stock worth $37,000 after purchasing an additional 131 shares during the last quarter. Symmetry Partners LLC boosted its stake in shares of CVS Health by 2.5% during the 3rd quarter. Symmetry Partners LLC now owns 5,826 shares of the pharmacy operator’s stock worth $439,000 after acquiring an additional 141 shares in the last quarter. Harbor Capital Advisors Inc. boosted its stake in shares of CVS Health by 72.1% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock worth $26,000 after acquiring an additional 142 shares in the last quarter. HF Advisory Group LLC boosted its stake in shares of CVS Health by 2.9% during the 3rd quarter. HF Advisory Group LLC now owns 5,219 shares of the pharmacy operator’s stock worth $393,000 after acquiring an additional 145 shares in the last quarter. Finally, United Asset Strategies Inc. boosted its stake in shares of CVS Health by 1.8% during the 3rd quarter. United Asset Strategies Inc. now owns 8,852 shares of the pharmacy operator’s stock worth $667,000 after acquiring an additional 154 shares in the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.